Dioxaphetyl butyrate

Dioxaphetyl butyrate

Clinical data
Synonyms	Amidalgon, Spasmoxal
Routes of administration	Oral, Other ROA Unknown
ATC code	none
Legal status
Legal status	AU: S9 (Prohibited) CA: Schedule I DE: Anlage I (Authorized scientific use only) US: Schedule I
Identifiers
IUPAC name Ethyl 4-morpholin-4-yl-2,2-di(phenyl)butanoate
CAS Number	467-86-7 Y
PubChem CID	48194
ChemSpider	43838 N
UNII	G751H98FY4
ECHA InfoCard	100.006.731
Chemical and physical data
Formula	C22H27NO3
Molar mass	353.45 g/mol
3D model (JSmol)	Interactive image
SMILES CCOC(=O)C(CCN1CCOCC1)(c1ccccc1)c1ccccc1
InChI InChI=1S/C22H27NO3/c1-2-26-21(24)22(19-9-5-3-6-10-19,20-11-7-4-8-12-20)13-14-23-15-17-25-18-16-23/h3-12H,2,13-18H2,1H3 N Key:LQGIXNQCOXNCRP-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Dioxaphetyl butyrate (INN; trade names Amidalgon, Spasmoxal) is an opioid analgesic which is a diphenylacetic acid derivative, related to other open-chain opioid drugs such as dextropropoxyphene, levacetylmethadol (LAAM), lefetamine and dimenoxadol.

It produces similar effects to other opioids, including dependence, euphoria, analgesia, sedation, constipation, dizziness and nausea.

In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9621 and a 2013 annual aggregrate manufacturing quota of zero.

References